Peer-reviewedCC BYAlzheimer's & Dementia : the Journal of the Alzheimer's Association
Emerging directions in tauopathy research
Abstract
The Tau Global Conference 2025, hosted by the Alzheimer's Association, CurePSP, and the Rainwater Charitable Foundation, convened international experts from academia, industry, government, and philanthropy to explore advances and challenges in tauopathy research. The meeting highlighted progress across tau biology, including emerging models of tau regulation, degradation, and propagation; advances in biomarker development for the diagnosis and staging of tauopathies; and evolving therapeutic strategies targeting diverse aspects of tau pathophysiology. Discussions also emphasized the importance of cross-sector collaboration, and global initiatives to address disparities in tau research. This report synthesizes key insights from the conference and underscores the critical role of interdisciplinary, biomarker-driven, and globally inclusive approaches in accelerating the translation of tau research into effective clinical applications.
Related
- Artificial intelligence in breast cancer research: a systematic review and bibliometric analysis of emerging trends and future directions
- Scabies Diagnosis: A Narrative Review of Diagnostic Methods, Clinical Misdiagnosis, and Emerging Directions
- Modern hysteroscopic management of congenital uterine anomalies: current techniques, emerging technologies, and future directions
- Incident versus prevalent progressive supranuclear palsy: analyses of U.S. Alzheimer's Disease Research Centers data indicate clinical and neuropathological features of a relatively common and underrecognized tauopathy in the aging brain.
- Artificial Intelligence in Voice Disorders: Current Landscape, Emerging Applications and Future Directions
BibTeX
@article{buee2026emerging,
title = {{Emerging directions in tauopathy research}},
author = {Luc Buée and Kristin Wildsmith and Suvarna Alladi and Taylor Bertucci and Delphine Boche and Kathryn Bowles and Adam Boxer and Jennifer Brummet and Sarah Devos and Kristophe Diaz and Anna Jane Dreyer and Karen Duff and Claudia Duran-Aniotz and Claire Durrant and Kurt Farrell and Igor Fontana and Nicolai Franzmeier and Bess Frost and Kanta Horie and Petr Kaňovský and Aimee Kao and Simin Mahinrad and Maura Malpetti and Huw Morris and Carla Palleis and Leonard Petrucelli and Jessica Rexach and Larisa Reyderman and Amy Rommel and James Rowe and Sandra Sanabria Bohórquez and Chihiro Sato and Michael Schöll and Anja Schneider and Rohan de Silva and Heather Snyder and Lawren Vandevrede and Andrew Varga and Jacob Vogel and Felix Yeh and Andrew Yoo and Maria Carrillo},
journal = {Alzheimer's \& Dementia : the Journal of the Alzheimer's Association},
year = {2026},
month = jun,
doi = {10.1002/alz.71431},
url = {https://hal.science/hal-05762119v1},
note = {CC BY},
}
RIS
TY - JOUR
TI - Emerging directions in tauopathy research
AU - Luc Buée
AU - Kristin Wildsmith
AU - Suvarna Alladi
AU - Taylor Bertucci
AU - Delphine Boche
AU - Kathryn Bowles
AU - Adam Boxer
AU - Jennifer Brummet
AU - Sarah Devos
AU - Kristophe Diaz
AU - Anna Jane Dreyer
AU - Karen Duff
AU - Claudia Duran-Aniotz
AU - Claire Durrant
AU - Kurt Farrell
AU - Igor Fontana
AU - Nicolai Franzmeier
AU - Bess Frost
AU - Kanta Horie
AU - Petr Kaňovský
AU - Aimee Kao
AU - Simin Mahinrad
AU - Maura Malpetti
AU - Huw Morris
AU - Carla Palleis
AU - Leonard Petrucelli
AU - Jessica Rexach
AU - Larisa Reyderman
AU - Amy Rommel
AU - James Rowe
AU - Sandra Sanabria Bohórquez
AU - Chihiro Sato
AU - Michael Schöll
AU - Anja Schneider
AU - Rohan de Silva
AU - Heather Snyder
AU - Lawren Vandevrede
AU - Andrew Varga
AU - Jacob Vogel
AU - Felix Yeh
AU - Andrew Yoo
AU - Maria Carrillo
PY - 2026
DA - 2026/06/21
JO - Alzheimer's & Dementia : the Journal of the Alzheimer's Association
DO - 10.1002/alz.71431
UR - https://hal.science/hal-05762119v1
AB - The Tau Global Conference 2025, hosted by the Alzheimer's Association, CurePSP, and the Rainwater Charitable Foundation, convened international experts from academia, industry, government, and philanthropy to explore advances and challenges in tauopathy research. The meeting highlighted progress across tau biology, including emerging models of tau regulation, degradation, and propagation; advances in biomarker development for the diagnosis and staging of tauopathies; and evolving therapeutic strategies targeting diverse aspects of tau pathophysiology. Discussions also emphasized the importance of cross-sector collaboration, and global initiatives to address disparities in tau research. This report synthesizes key insights from the conference and underscores the critical role of interdisciplinary, biomarker-driven, and globally inclusive approaches in accelerating the translation of tau research into effective clinical applications.
SN - 1552-5260
SN - 1552-5279
ER -